{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T03:50:09Z","timestamp":1747194609583,"version":"3.40.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is no unified treatment standard for patients with extranodal NK\/T-cell lymphoma (ENKTL). Cancer neoantigens are the result of somatic mutations and cancer-specific. Increased number of somatic mutations are associated with anti-cancer effects. Screening out ENKTL-specific neoantigens on the surface of cancer cells relies on the understanding of ENKTL mutation patterns. Hence, it is imperative to identify ENKTL-specific genes for ENKTL diagnosis, the discovery of tumor-specific neoantigens and the development of novel therapeutic strategies. We investigated the gene signatures of ENKTL patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We collected the peripheral blood of a pair of twins for sequencing to identify unique variant genes. One of the twins is diagnosed with ENKTL. Seventy samples were analyzed by Robust Multi-array Analysis (RMA). Two methods (elastic net and Support Vector Machine-Recursive Feature Elimination) were used to select unique genes. Next, we performed functional enrichment analysis and pathway enrichment analysis. Then, we conducted single-sample gene set enrichment analysis of immune infiltration and validated the expression of the screened markers with limma packages.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We screened out 126 unique variant genes. Among them, 11 unique genes were selected by the combination of elastic net and Support Vector Machine-Recursive Feature Elimination. Subsequently, GO and KEGG analysis indicated the biological function of identified unique genes. GSEA indicated five immunity-related pathways with high signature scores. In patients with ENKTL and the group with high signature scores, a proportion of functional immune cells are all of great infiltration. We finally found that CDC27, ZNF141, FCGR2C and NES were four significantly differential genes in ENKTL patients. ZNF141, FCGR2C and NES were upregulated in patients with ENKTL, while CDC27 was significantly downregulated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We identified four ENKTL markers (ZNF141, FCGR2C, NES and CDC27) in patients with extranodal NK\/T-cell lymphoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-09023-9","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T22:02:32Z","timestamp":1638828152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The identification of gene signatures in patients with extranodal NK\/T-cell lymphoma from a pair of twins"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8639-4677","authenticated-orcid":false,"given":"Yang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaicheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangqi","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9958-9892","authenticated-orcid":false,"given":"Huashan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"9023_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13045-019-0717-6","volume":"12","author":"N Somasundaram","year":"2019","unstructured":"Somasundaram N, Lim JQ, Ong CK, Lim ST. Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL). J Hematol Oncol. 2019;12:28.","journal-title":"J Hematol Oncol"},{"key":"9023_CR2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41379-019-0415-5","volume":"33","author":"IA Montes-Mojarro","year":"2020","unstructured":"Montes-Mojarro IA, Chen BJ, Ramirez-Ibarguen AF, Quezada-Fiallos CM, P\u00e9rez-B\u00e1ez WB, Due\u00f1as D, et al. Mutational profile and EBV strains of extranodal NK\/T-cell lymphoma, nasal type in Latin America. Mod Pathol. 2020;33:781\u201391.","journal-title":"Mod Pathol"},{"key":"9023_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.clml.2019.10.010","volume":"20","author":"L Huang","year":"2020","unstructured":"Huang L, Wu Y, Wang Y, Xie Y, Wu F, Li S, et al. Prognostic nomogram for overall survival in early stage extranodal natural killer\/T cell lymphoma treated with high-dose radiotherapy. Clin Lymphoma Myeloma Leuk. 2020;20:289\u201395.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"9023_CR4","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1080\/10428194.2020.1811864","volume":"61","author":"P Ghione","year":"2020","unstructured":"Ghione P, Qi S, Imber BS, Seshan V, Moskowitz A, Galasso N, et al. Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population. Leuk Lymphoma. 2020;61:3331\u201341.","journal-title":"Leuk Lymphoma"},{"key":"9023_CR5","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.5045\/br.2020.S011","volume":"55","author":"SH Jeong","year":"2020","unstructured":"Jeong SH. Extranodal NK\/T cell lymphoma. Blood Res. 2020;55:S63\u2013s71.","journal-title":"Blood Res"},{"key":"9023_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11864-020-0709-3","volume":"21","author":"MR Gaballa","year":"2020","unstructured":"Gaballa MR, Ramos CA. Cellular immunotherapy in lymphoma: beyond CART cells. Curr Treat Options in Oncol. 2020;21:21.","journal-title":"Curr Treat Options in Oncol"},{"key":"9023_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.humpath.2017.10.029","volume":"71","author":"PK Panjwani","year":"2018","unstructured":"Panjwani PK, Charu V, DeLisser M, Molina-Kirsch H, Natkunam Y, Zhao S. Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes. Hum Pathol. 2018;71:91\u20139.","journal-title":"Hum Pathol"},{"key":"9023_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41392-020-00331-3","volume":"5","author":"J Cai","year":"2020","unstructured":"Cai J, Liu P, Huang H, Li Y, Ma S, Zhou H, et al. Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer\/T cell lymphoma. Signal Transduct Target Ther. 2020;5:289.","journal-title":"Signal Transduct Target Ther"},{"key":"9023_CR9","first-page":"7034","volume":"12","author":"K Lv","year":"2020","unstructured":"Lv K, Li X, Yu H, Chen X, Zhang M, Wu X. Selection of new immunotherapy targets for NK\/T cell lymphoma. Am J Transl Res. 2020;12:7034\u201347.","journal-title":"Am J Transl Res"},{"issue":"13","key":"9023_CR10","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1158\/1078-0432.CCR-20-4338","volume":"27","author":"PJ Vellanki","year":"2021","unstructured":"Vellanki PJ, Mulkey F, Jaigirdar AA, Rodriguez L, Wang Y, Xu Y. FDA approval summary: Nivolumab with Ipilimumab and chemotherapy for metastatic non-small cell lung cancer, a collaborative project Orbis review. Clin Cancer Res. 2021;27(13):3522\u20137.","journal-title":"Clin Cancer Res"},{"issue":"23","key":"9023_CR11","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1182\/blood.2020008865","volume":"137","author":"P Strati","year":"2021","unstructured":"Strati P, Ahmed S, Furqan F, Fayad LE, Lee HJ, Iyer SP, et al. Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma. Blood. 2021;137(23):3272\u20136.","journal-title":"Blood"},{"issue":"10286","key":"9023_CR12","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet. 2021;397(10286):1750\u201369.","journal-title":"Lancet."},{"key":"9023_CR13","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","volume":"115","author":"Y Huang","year":"2010","unstructured":"Huang Y, de Reyni\u00e8s A, de Leval L, Ghazi B, Martin-Garcia N, Travert M, et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type. Blood. 2010;115:1226\u201337.","journal-title":"Blood"},{"key":"9023_CR14","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1038\/ncomms7025","volume":"6","author":"C K\u00fc\u00e7\u00fck","year":"2015","unstructured":"K\u00fc\u00e7\u00fck C, Jiang B, Hu X, Zhang W, Chan JK, Xiao W, et al. Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells. Nat Commun. 2015;6:6025.","journal-title":"Nat Commun"},{"issue":"9","key":"9023_CR15","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.3324\/haematol.2020.254276","volume":"106","author":"G Dong","year":"2020","unstructured":"Dong G, Li Y, Lee L, Liu X, Shi Y, Liu X, et al. Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1. Haematologica. 2020;106(9):2427\u201338.","journal-title":"Haematologica."},{"key":"9023_CR16","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/leu.2009.3","volume":"23","author":"J Iqbal","year":"2009","unstructured":"Iqbal J, Kucuk C, Deleeuw RJ, Srivastava G, Tam W, Geng H, et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia. 2009;23:1139\u201351.","journal-title":"Leukemia"},{"key":"9023_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ajpath.2012.09.012","volume":"182","author":"C K\u00fc\u00e7\u00fck","year":"2013","unstructured":"K\u00fc\u00e7\u00fck C, Hu X, Iqbal J, Gaulard P, Klinkebiel D, Cornish A, et al. HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms. Am J Pathol. 2013;182:49\u201355.","journal-title":"Am J Pathol"},{"key":"9023_CR18","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMra1814259","volume":"380","author":"A Rajkomar","year":"2019","unstructured":"Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380:1347\u201358.","journal-title":"N Engl J Med"},{"key":"9023_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41583-020-00395-8","volume":"22","author":"A Saxe","year":"2021","unstructured":"Saxe A, Nelli S. If deep learning is the answer, what is the question? Nat Rev Neurosci. 2021;22:55\u201367.","journal-title":"Nat Rev Neurosci"},{"key":"9023_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41568-020-00327-9","volume":"21","author":"A Kleppe","year":"2021","unstructured":"Kleppe A, Skrede OJ. Designing deep learning studies in cancer diagnostics. Nat Rev Cancer. 2021;21:199\u2013211.","journal-title":"Nat Rev Cancer"},{"key":"9023_CR21","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1038\/s41467-020-17347-6","volume":"11","author":"L Huang","year":"2020","unstructured":"Huang L, Wang L. Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma. Nat Commun. 2020;11:3556.","journal-title":"Nat Commun"},{"key":"9023_CR22","first-page":"3248","volume":"26","author":"Z Yang","year":"2020","unstructured":"Yang Z, LaRiviere MJ. A multianalyte panel consisting of extracellular vesicle miRNAs and mRNAs, cfDNA, and CA19-9 shows utility for diagnosis and staging of pancreatic ductal adenocarcinoma. Adv Mater. 2020;26:3248\u201358.","journal-title":"Adv Mater"},{"key":"9023_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nmeth.4551","volume":"15","author":"D Bzdok","year":"2018","unstructured":"Bzdok D, Krzywinski M, Altman N. Machine learning: supervised methods. Nat Methods. 2018;15:5\u20136.","journal-title":"Nat Methods"},{"key":"9023_CR24","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nbt1206-1565","volume":"24","author":"WS Noble","year":"2006","unstructured":"Noble WS. What is a support vector machine? Nat Biotechnol. 2006;24:1565\u20137.","journal-title":"Nat Biotechnol"},{"key":"9023_CR25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41422-020-0322-9","volume":"30","author":"Y Cao","year":"2020","unstructured":"Cao Y, Li L, Xu M. The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals. Cell Res. 2020;30:717\u201331.","journal-title":"Cell Res"},{"key":"9023_CR26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1055\/a-1301-3841","volume":"53","author":"R Leenhardt","year":"2021","unstructured":"Leenhardt R, Souchaud M, Houist G, Le Mouel JP, Saurin JC, Cholet F, et al. A neural network-based algorithm for assessing the cleanliness of small bowel during capsule endoscopy. Endoscopy. 2021;53:932\u20136.","journal-title":"Endoscopy"},{"key":"9023_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1\u201322.","journal-title":"J Stat Softw"},{"key":"9023_CR28","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1093\/nar\/gkv229","volume":"43","author":"JJ Hughey","year":"2015","unstructured":"Hughey JJ, Butte AJ. Robust meta-analysis of gene expression using the elastic net. Nucleic Acids Res. 2015;43:e79.","journal-title":"Nucleic Acids Res"},{"key":"9023_CR29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1200\/JCO.2016.68.2153","volume":"35","author":"J Qiu","year":"2017","unstructured":"Qiu J, Peng B, Tang Y, Qian Y, Guo P, Li M, et al. CpG methylation signature predicts recurrence in early-stage hepatocellular carcinoma: results from a multicenter study. J Clin Oncol. 2017;35:734\u201342.","journal-title":"J Clin Oncol"},{"key":"9023_CR30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462:108\u201312.","journal-title":"Nature"},{"key":"9023_CR31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/jclinpath-2013-201454","volume":"66","author":"Z Ye","year":"2013","unstructured":"Ye Z, Cao Q, Niu G, Liang Y, Liu Y, Jiang L, et al. p63 and p53 expression in extranodal NK\/T cell lymphoma, nasal type. J Clin Pathol. 2013;66:676\u201380.","journal-title":"J Clin Pathol"},{"key":"9023_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-019-0716-7","volume":"12","author":"S de Mel","year":"2019","unstructured":"de Mel S, Hue SS, Jeyasekharan AD, Chng WJ, Ng SB. Molecular pathogenic pathways in extranodal NK\/T cell lymphoma. J Hematol Oncol. 2019;12:33.","journal-title":"J Hematol Oncol"},{"key":"9023_CR33","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3389\/fphar.2020.00820","volume":"11","author":"H Shi","year":"2020","unstructured":"Shi H, Li C, Feng W, Yue J, Song J, Peng A, et al. BCL11A is oncogenic and predicts poor outcomes in natural killer\/T-cell lymphoma. Front Pharmacol. 2020;11:820.","journal-title":"Front Pharmacol"},{"key":"9023_CR34","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1182\/blood-2012-08-450494","volume":"121","author":"J Yan","year":"2013","unstructured":"Yan J, Ng SB, Tay JL, Lin B, Koh TL, Tan J, et al. EZH2 overexpression in natural killer\/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity. Blood. 2013;121:4512\u201320.","journal-title":"Blood"},{"issue":"12","key":"9023_CR35","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.3390\/cancers12123548","volume":"12","author":"KJ Ryu","year":"2020","unstructured":"Ryu KJ, Lee JY, Choi ME, Yoon SE, Cho J, Ko YH, et al. Serum-derived exosomal MicroRNA profiles can predict poor survival outcomes in patients with extranodal natural killer\/T-cell lymphoma. Cancers (Basel). 2020;12(12):3548.","journal-title":"Cancers (Basel)"},{"key":"9023_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1146\/annurev-pharmtox-010814-124502","volume":"55","author":"M Vidyasagar","year":"2015","unstructured":"Vidyasagar M. Identifying predictive features in drug response using machine learning: opportunities and challenges. Annu Rev Pharmacol Toxicol. 2015;55:15\u201334.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9023_CR37","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41551-018-0265-3","volume":"2","author":"H Im","year":"2018","unstructured":"Im H, Pathania D. Design and clinical validation of a point-of-care device for the diagnosis of lymphoma via contrast-enhanced microholography and machine learning. Nat Biomed Eng. 2018;2:666\u201374.","journal-title":"Nat Biomed Eng"},{"key":"9023_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nm0102-68","volume":"8","author":"MA Shipp","year":"2002","unstructured":"Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002;8:68\u201374.","journal-title":"Nat Med"},{"key":"9023_CR39","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1038\/s41467-020-19950-z","volume":"11","author":"H Julkunen","year":"2020","unstructured":"Julkunen H, Cichonska A. Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects. Nat Commun. 2020;11:6136.","journal-title":"Nat Commun"},{"key":"9023_CR40","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.3892\/or.2015.4305","volume":"34","author":"L Sun","year":"2015","unstructured":"Sun L, Zhao Y, Shi H, Ma C, Wei L. LMP1 promotes nasal NK\/T-cell lymphoma cell function by eIF4E via NF-\u03baB pathway. Oncol Rep. 2015;34:3264\u201371.","journal-title":"Oncol Rep"},{"key":"9023_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.humpath.2017.12.006","volume":"73","author":"T Takayama","year":"2018","unstructured":"Takayama T, Shin S, Kang S, Kim SJ, Kim WS, Ko YH. Identification of T-cell receptor expression in EBV-positive neoplastic cells in extranodal NK\/T-cell lymphoma, nasal-type, and comparison with T-cell receptor gene rearrangement by BIOMED-2 assay. Hum Pathol. 2018;73:51\u20138.","journal-title":"Hum Pathol"},{"key":"9023_CR42","doi-asserted-by":"publisher","first-page":"17764","DOI":"10.18632\/oncotarget.3776","volume":"6","author":"S Lee","year":"2015","unstructured":"Lee S, Park HY, Kang SY, Kim SJ, Hwang J, Lee S, et al. Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type. Oncotarget. 2015;6:17764\u201376.","journal-title":"Oncotarget"},{"key":"9023_CR43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1189\/jlb.1A0914-459RR","volume":"98","author":"SJ Oh","year":"2015","unstructured":"Oh SJ, Ahn S, Jin YH, Ishifune C, Kim JH, Yasutomo K, et al. Notch 1 and Notch 2 synergistically regulate the differentiation and function of invariant NKT cells. J Leukoc Biol. 2015;98:781\u20139.","journal-title":"J Leukoc Biol"},{"key":"9023_CR44","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fonc.2020.00488","volume":"10","author":"Y Song","year":"2020","unstructured":"Song Y, Song W, Li Z, Song W, Wen Y, Li J, et al. CDC27 promotes tumor progression and affects PD-L1 expression in T-cell lymphoblastic lymphoma. Front Oncol. 2020;10:488.","journal-title":"Front Oncol"},{"key":"9023_CR45","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/hmg\/2.10.1571","volume":"2","author":"N Tommerup","year":"1993","unstructured":"Tommerup N, Aagaard L, Lund CL, Boel E, Baxendale S, Bates GP, et al. A zinc-finger gene ZNF141 mapping at 4p16.3\/D4S90 is a candidate gene for the Wolf-Hirschhorn (4p-) syndrome. Hum Mol Genet. 1993;2:1571\u20135.","journal-title":"Hum Mol Genet"},{"key":"9023_CR46","doi-asserted-by":"publisher","first-page":"e0189498","DOI":"10.1371\/journal.pone.0189498","volume":"13","author":"OY Gorlova","year":"2018","unstructured":"Gorlova OY, Li Y, Gorlov I, Ying J, Chen WV, Assassi S, et al. Gene-level association analysis of systemic sclerosis: a comparison of African-Americans and White populations. PLoS One. 2018;13:e0189498.","journal-title":"PLoS One"},{"issue":"5","key":"9023_CR47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/cells8050497","volume":"8","author":"P Sharma","year":"2019","unstructured":"Sharma P, Alsharif S, Fallatah A, Chung BM. Intermediate filaments as effectors of cancer development and metastasis: a focus on keratins, vimentin, and nestin. Cells. 2019;8(5):497.","journal-title":"Cells"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-09023-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-09023-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-09023-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T04:03:54Z","timestamp":1666757034000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-09023-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["9023"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-09023-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2021,12,6]]},"assertion":[{"value":"20 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the ethics administration office of West China Hospital, Sichuan University. All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by the ethics administration office of West China Hospital, Sichuan University. The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1303"}}